Whan In Pharm Statistics

Total Valuation

Whan In Pharm has a market cap or net worth of KRW 180.30 billion. The enterprise value is 126.49 billion.

Market Cap	180.30B
Enterprise Value	126.49B

Important Dates

The next estimated earnings date is Wednesday, July 30, 2025.

Earnings Date	Jul 30, 2025
Ex-Dividend Date	Dec 27, 2024

Share Statistics

Whan In Pharm has 15.27 million shares outstanding.

Current Share Class	15.27M
Shares Outstanding	15.27M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	28.36%
Owned by Institutions (%)	15.94%
Float	10.94M

Valuation Ratios

The trailing PE ratio is 9.28 and the forward PE ratio is 8.76.

PE Ratio	9.28
Forward PE	8.76
PS Ratio	0.70
PB Ratio	0.48
P/TBV Ratio	0.49
P/FCF Ratio	60.17
P/OCF Ratio	8.55
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 4.54, with an EV/FCF ratio of 42.21.

EV / Earnings	6.51
EV / Sales	0.49
EV / EBITDA	4.54
EV / EBIT	6.74
EV / FCF	42.21

Financial Position

The company has a current ratio of 4.52, with a Debt / Equity ratio of 0.00.

Current Ratio	4.52
Quick Ratio	2.77
Debt / Equity	0.00
Debt / EBITDA	0.03
Debt / FCF	0.26
Interest Coverage	753.41

Financial Efficiency

Return on equity (ROE) is 5.26% and return on invested capital (ROIC) is 3.12%.

Return on Equity (ROE)	5.26%
Return on Assets (ROA)	2.73%
Return on Invested Capital (ROIC)	3.12%
Return on Capital Employed (ROCE)	4.82%
Revenue Per Employee	422.56M
Profits Per Employee	31.80M
Employee Count	611
Asset Turnover	0.61
Inventory Turnover	2.42

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -19.00% in the last 52 weeks. The beta is 0.31, so Whan In Pharm's price volatility has been lower than the market average.

Beta (5Y)	0.31
52-Week Price Change	-19.00%
50-Day Moving Average	11,420.60
200-Day Moving Average	12,269.40
Relative Strength Index (RSI)	63.76
Average Volume (20 Days)	17,471

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Whan In Pharm had revenue of KRW 258.19 billion and earned 19.43 billion in profits. Earnings per share was 1,272.45.

Revenue	258.19B
Gross Profit	89.70B
Operating Income	18.46B
Pretax Income	21.52B
Net Income	19.43B
EBITDA	27.56B
EBIT	18.46B
Earnings Per Share (EPS)	1,272.45

Full Income Statement

Balance Sheet

The company has 54.60 billion in cash and 788.15 million in debt, giving a net cash position of 53.81 billion or 3,524.79 per share.

Cash & Cash Equivalents	54.60B
Total Debt	788.15M
Net Cash	53.81B
Net Cash Per Share	3,524.79
Equity (Book Value)	375.99B
Book Value Per Share	24,627.32
Working Capital	161.02B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 21.09 billion and capital expenditures -18.09 billion, giving a free cash flow of 3.00 billion.

Operating Cash Flow	21.09B
Capital Expenditures	-18.09B
Free Cash Flow	3.00B
FCF Per Share	196.27

Full Cash Flow Statement

Margins

Gross margin is 34.74%, with operating and profit margins of 7.15% and 7.53%.

Gross Margin	34.74%
Operating Margin	7.15%
Pretax Margin	8.33%
Profit Margin	7.53%
EBITDA Margin	10.68%
EBIT Margin	7.15%
FCF Margin	1.16%

Dividends & Yields

This stock pays an annual dividend of 300.00, which amounts to a dividend yield of 2.54%.

Dividend Per Share	300.00
Dividend Yield	2.54%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	23.57%
Buyback Yield	n/a
Shareholder Yield	2.54%
Earnings Yield	10.78%
FCF Yield	1.66%

Dividend Details

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

The last stock split was on April 14, 2010. It was a forward split with a ratio of 2.

Last Split Date	Apr 14, 2010
Split Type	Forward
Split Ratio	2

Scores

Whan In Pharm has an Altman Z-Score of 4.65.

Altman Z-Score	4.65
Piotroski F-Score	n/a